参考文献/References:
[1] XIA C,DONG X,LI H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chin Med J(Engl),2022,135(5):584-590.
[2] 周家琛,魏文强,赫捷,等.2000—2015年中国肿瘤登记地区胃癌发病趋势及年龄变化[J].实用肿瘤学杂志,2020,34(1):1-5.
[3] YUAN L,XU Z Y,RUAN S M,et al.Long non-coding RNAs towards precision medicine in gastric cancer:early diagnosis,treatment,and drug resistance[J].Mol Cancer,2020,19(1):96.
[4] KRAMER S J,AMANAVICIUS N,STAANUM P F,et al.Incidental finding of pulmonary embolism at workup before SIRT[J].Clin Nucl Med,2022,47(2):e201-e202.
[5] LUO Z,MA G,LU Y,et al.Characteristics and 6-Month mortality of medical oncology patients with incidental and symptomatic pulmonary embolism:A single institutional retros-pective longitudinal analysis[J].Clin Appl Thromb Hemost,2023,29:10760296231155177.
[6] MAHé I,CHAPELLE C,PLAISANCE L,et al.Management of cancer-associated thrombosis in France:A national survey among vascular disease and supportive care specialists[J].Cancers(Basel),2022,14(17):4143.
[7] HOUGHTON D E,VLAZNY D T,CASANEGRA A I,et al.Bleeding in patients with gastrointestinal cancer compared with nongastrointestinal cancer treated with apixaban,rivaroxaban,or enoxaparin for acute venous thromboembolism[J].Mayo Clin Proc,2021,96(11):2793-2805.
[8] WANG W D,WEI J P,GAO R Q,et al.A retrospective study of the role of preoperative ultrasonography in the detection of deep vein thrombosis in 1750 patients with gastric and colorectal cancers[J].Thromb Res,2022,216:52-58.
[9] KIM E,KIM H,YEO M K,et al.Identification of a novel long non-coding RNA,lnc-ATMIN-4:2,and its clinicopathological and prognostic significance in advanced gastric cancer[J].Cancer Genomics Proteomics,2022,19(6):761-772.
[10] ZhANG N,WANG B,MA C,et al.LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization[J].J Exp Clin Cancer Res,2023,42(1):89.
[11] ASHRAFIZADEH M,MOHAN C D,RANGAPPA S,et al.Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers:Roles in cancer progression and therapeutic response[J].Med Res Rev,2023 43(5):1263-1321.
[12] DANG Y,OUYANG X,ZHANG F,et al.Circular RNAs expression profiles in human gastric cancer[J].Sci Rep,2017,7(1):9060.
[13] 王昊,袁建松.消化道恶性肿瘤并发静脉血栓栓塞的分子机制与风险评估[J].中国分子心脏病学杂志,2021,21(6):4380-4383.
[14] 段炼,何国琳.妊娠期D-二聚体升高带来的临床困惑[J].四川大学学报(医学版),2022,53(3):543-548.
[15] YU H,QIN X K,YIN K W,et al.EphB6 deficiency in intestinal neurons promotes tumor growth in colorectal cancer by neurotransmitter GABA signaling[J].Carcinogenesis,2023,44(9):682-694.
[16] HANOVER G,VIZEACOUMAR F S,BANERJEE S L,et al.Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR[J].Cell Rep,2023,42(7):112670.
[17] LIU J,XU B,XU G,et al.Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor[J].Cancer Biomark,2017,19(3):241-248.